6-K - AURORA CANNABIS INC (0001683541) (Filer)

SUPPL - AURORA CANNABIS INC (0001683541) (Filer)

F-X - AURORA CANNABIS INC (0001683541) (Subject)

F-10 - AURORA CANNABIS INC (0001683541) (Filer)

6-K - AURORA CANNABIS INC (0001683541) (Filer)

6-K - AURORA CANNABIS INC (0001683541) (Filer)

6-K - AURORA CANNABIS INC (0001683541) (Filer)

6-K - AURORA CANNABIS INC (0001683541) (Filer)

6-K - AURORA CANNABIS INC (0001683541) (Filer)

6-K - AURORA CANNABIS INC (0001683541) (Filer)

NASDAQ | TSX: ACB Canada's Leading Medical Cannabis Company Expands Patient Offering with Innovative Dosage Solution EDMONTON, AB, April 15, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, has announced today the availability of medical cannabis concentrates to patients in the United Kingdom (UK). This launch marks the company's meaningful step in offering its proprietary cultivar-specific inhalable cannabis extracts in the UK market. These products are available to patients in Canada and Australia and this launch reinforces Aurora's commitment to expanding patient access to an even greater variety of high-quality,

Canada's Largest Medical Cannabis Company is an Honouree in The Globe and Mail's 2025 Report on Business Magazine's sixth annual Women Lead Here List EDMONTON, AB, March 31, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, has been named an honouree on the Globe & Mail's 2025 Report on Business, Women Lead Here list. This annual editorial benchmark recognizes the top publicly traded Canadian companies with the highest gender diversity at the executive level. "As a company with a leading purpose of bein

NASDAQ | TSX: ACB Canada's Largest Medical Cannabis Company to Participate as an Industry Leader in the Inaugural Regulatory Event in Washington, D.C. EDMONTON, AB, March 25, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to be attending, sponsoring and speaking at the 2025 Global Cannabis Regulatory Summit (GCRS), held within the U.S. Capitol Complex in Washington, D.C. on March 26-27, 2025. "The opportunity to speak on this global stage, underscores our position as industry leaders and d

NASDAQ | TSX: ACB Groundbreaking research at Aurora Coast, Aurora's world-class research and development facility, sets new standard in cannabis science EDMONTON, AB, March 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, is pleased to announce the Company's discovery of a novel source of genetic resistance against powdery mildew, PM2, that provides strong protection against this pathogen in cannabis sativa. The development of this proprietary genetic marker technology, which is now in use in Aurora's breeding program, is set to produce powdery mildew resistant cultivars that will be explored for commercial launc

Canada's Leading Medical Cannabis Company Broadens Innovative Product Portfolio to Growing Market in Australia EDMONTON, AB, Feb. 20, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, has announced today the company's extended pastille offerings in Australia. This expansion marks another meaningful step in Aurora's deep commitment to offering patients a diverse range of high-quality, premium medical cannabis products to meet their various needs and interests. "Expanding our portfolio of medical cannabi

 NASDAQ | TSX: ACB Largest Global Medical Cannabis Company Operating in Nationally Regulated Markets, Aurora Removes Concession Card Requirements to Access IndiMed Products in Australia EDMONTON, AB, Feb. 14, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the concession card requirement for patients to access medical cannabis products under the Company's IndiMed brand. By removing this eligibility barrier, any patient in Australia can now be prescribed IndiMed products, providing greater patient access to high quality medical can

NASDAQ | TSX: ACB Agreement Complements Existing Relationship Focused on the Supply of Premium Cannabis  EDMONTON, AB, February 6, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB) –the Canadian based leading global medical cannabis company, is pleased to announce a strategic supply agreement (the "Agreement") with SNDL Inc. ("SNDL"), a Canadian licensed producer and vertically integrated cannabis enterprise. Under this Agreement, SNDL is expected to supply Aurora with premium cannabis flower product grown at SNDL's indoor facility in

NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoYGenerates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoYAchieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third qu

NASDAQ | TSX: ACB Investment in the region continues with the launch of IndiMed, the company's first locally grown brand in Germany EDMONTON, AB, Jan. 23, 2025 /PRNewswire/ - Aurora Cannabis Inc. (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, announces today the launch of the company's first German-cultivated medical cannabis product, under the brand IndiMed. Manufactured at Aurora's leading EU-GMP facility in Leuna, Germany, the new brand offers a supply of high-quality, locally grown and sold, medical cannabis for the country's expanding patient base.

NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 5, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer,

SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)

SC 13G - AURORA CANNABIS INC (0001683541) (Subject)

SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)

SC 13G/A - AURORA CANNABIS INC (0001683541) (Subject)

NASDAQ | TSX: ACB Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoYGenerates Record Net Income of $31.2 Million, up 282% YoY, and Record Adjusted EBITDA1 of $23.1 Million, up 316% YoYAchieves Target of Positive Free Cash Flow1 in Q3, Generating $27.4 Million of Free Cash Flow1Maintains Strong Balance Sheet with $180 Million of Cash and Debt-Free Cannabis Business2EDMONTON, AB, Feb. 5, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the third qu

NASDAQ | TSX: ACB EDMONTON, AB, Jan. 22, 2025 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its third quarter 2025 on Wednesday, February 5, 2025 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the third quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, February 5, 2025 TIME: 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time WEBCAST: Click Here Miguel Martin, Executive Chairman and Chief Executive Officer,

NASDAQ | TSX: ACB Record Adjusted EBITDA1 of $10.1 Million, a YoY increase of 210%Quarterly Net Revenue1 up 29% YoY to $81.1 Million, with 41% growth in Global Medical CannabisRe-Affirms Target of Positive Free Cash Flow1 in the Quarter Ending December 31, 2024Maintains Strong Balance Sheet with ~$152 Million of Cash and a Debt-Free Cannabis Business2EDMONTON, AB, Nov. 6, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the second quarter fiscal 2025.

NASDAQ | TSX: ACB EDMONTON, AB, Oct. 24, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today announced today that it has scheduled a conference call to discuss the results for its second quarter 2025 on Wednesday, November 6, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the second quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, November 6, 2024 TIME:

Delivers Positive Free Cash Flow1 of $6.5 MillionIncreases Total Quarterly Net Revenue1 by 12% YoY to $83.4 Million, Record Net Revenue1 of $47.2 Million in Global Medical Cannabis  Generates Adjusted EBITDA1 of $4.9 Million, a YoY increase of 87%Ends the Fiscal Quarter with a Debt-Free Cannabis Business2 and a Cash Position of ~$182 Million EDMONTON, AB, Aug. 7, 2024 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025.

Delivers Positive Free Cash Flow1 of $6.5 MillionIncreases Total Quarterly Net Revenue1 by 12% YoY to $83.4 Million, Record Net Revenue1 of $47.2 Million in Global Medical Cannabis  Generates Adjusted EBITDA1 of $4.9 Million, a YoY increase of 87%Ends the Fiscal Quarter with a Debt-Free Cannabis Business2 and a Cash Position of ~$182 Million EDMONTON, AB, Aug. 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the first quarter fiscal 2025.

NASDAQ | TSX: ACB EDMONTON, AB, July 29, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its first quarter 2025 on Wednesday, August 7, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the first quarter 2025 before the opening of markets that same day. Conference Call Details DATE: Wednesday, August 7, 2024 TIME: 8:00 a.m. Eastern Time |

A roundup of the most newsworthy press releases from Cision Distribution this week TORONTO, July 12, 2024 /CNW/ - With thousands of press releases published each week, it can be difficult to keep up with everything on Cision. To help journalists and consumers stay on top of the week's most newsworthy and popular releases, here's a recap of some major stories from the week that shouldn't be missed. The list below includes the headline (with a link to the full text) and an excerpt from each story. Click on the press release headlines to access accompanying multimedia assets that

Delivers Record Annual Adjusted EBITDA1 of $12.8 Million NASDAQ | TSX: ACB Q4 Represents the Sixth Consecutive Quarter of Positive Adjusted EBITDA1Increased Total Quarterly Net Revenue 5% YoY to $67.4 Million, Global Medical Cannabis Net Revenue1 Grew by 20% YoY to $45.6 MillionEnded the Fiscal Year with a Cash Position of ~$180 Million with Cannabis Business Debt-Free2 Re-Affirms Target of Reaching Positive Free Cash Flow1 by December 31, 2024EDMONTON, AB, June 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced its financial and operational results for the fourth quarter and

NASDAQ | TSX: ACB EDMONTON, AB, June 7, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, announced today that it has scheduled a conference call to discuss the results for its fourth quarter and fiscal year 2024 on Thursday, June 20, 2024 at 8:00 a.m. Eastern Time | 6:00 a.m. Mountain Time. The Company will report its financial results for the fourth quarter fiscal year 2024 before the opening of markets that same day. Conference Call Details DATE: Thursday, June 20, 2024 TIME:

TD Cowen initiated coverage of Aurora Cannabis with a rating of Buy

Canaccord Genuity upgraded Aurora Cannabis from Hold to Buy

Canaccord Genuity upgraded Aurora Cannabis from Sell to Hold

Cantor Fitzgerald upgraded Aurora Cannabis from Neutral to Overweight

Stifel upgraded Aurora Cannabis from Sell to Hold

Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $10.75 from $9.60 previously

Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $9.60 from $9.50 previously

Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $9.50 from $8.30 previously

MKM Partners upgraded Aurora Cannabis from Sell to Neutral

Cantor Fitzgerald reiterated coverage of Aurora Cannabis with a rating of Neutral and set a new price target of $8.30 from $12.00 previously

NASDAQ | TSX: ACB Outgoing Chairman Ron Funk appointed Lead Independent Director, as part of Board leadership transition EDMONTON, AB, Sept. 20, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, today announced the appointments of CEO Miguel Martin to the additional role of Executive Chairman and outgoing Chairman Ron Funk as Lead Independent Director. Both appointments follow unanimous votes by Aurora's Board and are effective immediately. Mr. Martin has served as Chief Executiv

NASDAQ | TSX: ACB EDMONTON, AB, Aug. 12, 2024 /PRNewswire/ -  Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), a leading Canada-based global medical cannabis company, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held Friday August 9, 2024 by virtual webcast. The total number of shares represented by shareholders present in person (virtually) and by proxy at the Meeting was 14,855,306, representing 27.23% of Aurora's issued and outstanding common shares as of the record date. All of

 NASDAQ | TSX: ACB  Newly created directorship to be filled by Rajesh Uttamchandani EDMONTON, AB, May 15, 2024 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian based leading global medical cannabis company, announced today the appointment of Rajesh Uttamchandani to the Company's Board of Directors (the "Board"), effective today. Mr. Uttamchandani joins the Board with notable expertise in strategy development, innovation, human capital and governance. His impressive career is characterized by executive level roles with leadin

DOVER, DE / ACCESSWIRE / April 10, 2024 / International Star, Inc. (OTC:ILST) (the "Company" or "ILST") is pleased to announce the appointment of Todd Masse as its new Chief Executive Officer effective April 3, 2024. Mr. Masse has over 25 years of extensive experience managing and operating businesses across various industries, including startups, consumer-packaged goods, technology, and real estate. Since 2015, Mr. Masse has been a key figure in the cannabis industry, serving as both an entrepreneur and operator. His visionary leadership and innovative approach have driven growth and success in this rapidly evolving sector.Mr. Masse's achievements include serving as President of Cannabis C

 NASDAQ | TSX: ACB New brand promises great product and taste. First lineup includes flavour packed 50% THC pre-rolls and 1,000mg vapes EDMONTON, AB , Sept. 19, 2023 /PRNewswire/ - Aurora Cannabis (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, is launching a bold new brand, TASTY'S, to the Canadian adult market, designed to deliver on taste, potency, and price.  Anchored by a disruptive brand identity, TASTY'S celebrates its market arrival today in Toronto at Hall of Flowers, a premier cannabis trade show. The TASTY'S brand is available for cannabis enthusiasts, including buyers and budtenders, to experience and see firsthand that TASTY'S promises to deliver high

NASDAQ | TSX: ACB EDMONTON, AB, Aug. 14, 2023 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company opening the world to cannabis, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held today, Monday, August 14, 2023 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 92,897,315, representing 26.23% of Aurora's issued and outstanding common shares as of the record date. All of the matters put for

NASDAQ | TSX: ACB EDMONTON, AB, Nov. 14, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General and Special Meeting of Shareholders (the "Meeting") held today, Monday, November 14, 2022 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 92,937,078, representing 30.93% of Aurora's issued and outstanding common shares as of the record date.

NASDAQ | TSX: ACB EDMONTON, AB, Oct. 18, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce that the Company recently filed its management information circular (the "Circular") and related proxy materials (together with the Circular the "Meeting Materials") in advance of its annual and special meeting of shareholders (the "Meeting") scheduled for November 14, 2022. The Meeting Materials are now being mailed to Aurora's shareholders to provide inf

Newly created directorship to be filled by Chitwant Kohli, Senior Financial Executive NASDAQ | TSX: ACB  EDMONTON, AB, Jan. 4, 2022 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, announced today the appointment of Chitwant Kohli to the Company's Board of Directors (the "Board"), effective today. This is a newly added position that expands the Board to nine members, seven of whom are independent.  Mr. Kohli joins the Board following a fulsome career as a senior financi

NASDAQ | TSX: ACB EDMONTON, AB, Nov. 12, 2021 /PRNewswire/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ:ACB) (TSX:ACB), the Canadian company defining the future of cannabinoids worldwide, is pleased to announce the voting results from its Annual General Meeting of Shareholders (the "Meeting") held on Friday, November 12, 2021 by virtual webcast. The total number of shares represented by shareholders present in person and by proxy at the Meeting was 60,616,648, representing 30.6% of Aurora's issued and outstanding common shares. All of the matters put forward be